Clindamycin Phosphate; Benzoyl Peroxide Gel — FDA Drug Shortage

No longer listed by FDA — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Clindamycin Phosphate; Benzoyl Peroxide Gel (gel) from Teva Pharmaceuticals USA, Inc. with status No longer listed by FDA. The shortage was first posted on Aug 1, 2025.

Shortage details

Status
No longer listed by FDA
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0591-3916-68
Dosage Form
Gel
Presentation
Clindamycin Phosphate; Benzoyl Peroxide, Gel, 25 mg/1 g; 10 mg/1 g (NDC 0591-3916-68)
Initial Posting
Aug 1, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.